AccorHotels Arena
Paris, 75012, France
NCT Number: NCT04872075
The objective is to demonstrate if there is no increase in the risk of Sars-Cov-2 salivary carriage 7 days after a concert in the group participating in the event compared to a non participating group who stayed at home.
The hypothesis is that a systematic screening of Sars-Cov-2 within the 3 days before the event allows to control the risk of transmission and prevent cluster of transmission during the concert.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Paris, 75012, France
Before inclusion, the participants will be able to pre-register to the event via a website. They will get an appointment for an inclusion visit at the Accor Arena (Paris Bercy, France).
During 3 days (from D-3 to D-1), participants with a registration will come to the Accor Arena to have a rapid Sars-Cov-2 antigen test (results in 15 min).
If the test is positive, the participant will be contacted and managed by the medical team in charge of the national strategy for positives cases.
People with a negative test will be included and randomized :
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
People attending a concert in a closed area, with a mask
A nasopharyngeal swab at inclusion (up to 3 days before concert) to confirm eligibility
Saliva samples sent by participant at Day0 and Day7
Time frame: 7 days after the concert (-1/+8 days)
Prove the lack of increase of salivary carriage risk of SARS-CoV-2 on day 7 in participants present at the concert (experimental group) compared to non-participants at the event (control group)
Time frame: The day of the concert
Evaluation of the salivary carriage on day 0 (the concert day) despite a negative test within 3 days before the event and the conversion rate of salivary carriage between D0 and D7
Time frame: 7 days after the concert (-1/+8 days)
Comparison of the sequence of complete viral genome in participant with a positive test at day 7
Time frame: The day of the concert
Estimate the overall compliance of the mask wearing by the participants during the duration of the event (covering nose and mouth)
Time frame: The day of the concert
Identify the circumstances (place, time) of failure of accurate mask wearing by the participants
Time frame: The day of the concert
Estimate the feasibility and acceptability of using the Tousanticovid application
Assistance Publique - Hôpitaux de Paris
Other
Acronym: SPRING
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04924881
COVID-19, Coronaviridae Infections
Shatin, Hong Kong
View Trial DetailsNCT04939506
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial DetailsNCT04705116
COVID-19, Coronaviridae Infections
Los Angeles, California, United States
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial Details